A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7503 in Healthy Participants

Clinical trial NCT05143905 · COMPLETED

Trial details

NCT number: NCT05143905
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety Tolerability Pharmacokinetics Healthy Participants

Start date: 2021-12-06
Primary completion: 2022-11-09
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.